A detailed history of Titleist Asset Management, Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Titleist Asset Management, Ltd. holds 5,427 shares of ABBV stock, worth $930,839. This represents 0.21% of its overall portfolio holdings.

Number of Shares
5,427
Previous 5,502 1.36%
Holding current value
$930,839
Previous $738,000 18.83%
% of portfolio
0.21%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 12, 2023

SELL
$138.31 - $165.87 $10,373 - $12,440
-75 Reduced 1.36%
5,427 $0
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $5,234 - $6,003
-39 Reduced 0.7%
5,502 $738,000
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $24,083 - $30,618
-175 Reduced 3.06%
5,541 $849,000
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $39,462 - $48,961
299 Added 5.52%
5,716 $927,000
Q4 2021

Feb 17, 2022

BUY
$107.43 - $135.93 $581,948 - $736,332
5,417 New
5,417 $733,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Titleist Asset Management, Ltd. Portfolio

Follow Titleist Asset Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Titleist Asset Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Titleist Asset Management, Ltd. with notifications on news.